Skip to main content

Articles

Page 245 of 335

  1. Loss of lean body mass (LBM) is a common occurrence after treatment for breast cancer and is related to deleterious metabolic health outcomes [Clin Oncol, 22(4):281–288, 2010; Appl Physiol Nutr Metab, 34(5):950–9...

    Authors: Cameron McDonald, Judy Bauer, Sandra Capra and Joseph Coll
    Citation: BMC Cancer 2014 14:264
  2. Evaluation of the effectiveness of a patient decision aid (nurse-managed telephone support line and/or colorectal cancer screening website), distributed to patients by their family physician, in improving feca...

    Authors: Kathleen Clouston, Alan Katz, Patricia J Martens, Jeff Sisler, Donna Turner, Michelle Lobchuk, Susan McClement and Gary Crow
    Citation: BMC Cancer 2014 14:263
  3. Cathepsin X is a cysteine protease involved in mechanisms of malignant progression. It is secreted from tumour cells as a proenzyme and may serve to predict the disease status and risk of death for cancer pati...

    Authors: Tjaša Vižin, Ib Jarle Christensen, Michael Wilhelmsen, Hans Jørgen Nielsen and Janko Kos
    Citation: BMC Cancer 2014 14:259
  4. STAT1 has been attributed a function as tumor suppressor. However, in breast cancer data from microarray analysis indicated a predictive value of high mRNA expression levels of STAT1 and STAT1 target genes bel...

    Authors: Piotr Tymoszuk, Pornpimol Charoentong, Hubert Hackl, Rita Spilka, Elisabeth Müller-Holzner, Zlatko Trajanoski, Peter Obrist, Françoise Revillion, Jean-Philippe Peyrat, Heidi Fiegl and Wolfgang Doppler
    Citation: BMC Cancer 2014 14:257
  5. Tissue-transglutaminase (TG2), a dual function G-protein, plays key roles in cell differentiation and migration. In our previous studies we reported the mechanism of TG2-induced cell differentiation. In presen...

    Authors: Ambrish Kumar, Jianjun Hu, Holly A LaVoie, Kenneth B Walsh, Donald J DiPette and Ugra S Singh
    Citation: BMC Cancer 2014 14:256

    The Erratum to this article has been published in BMC Cancer 2016 16:609

  6. A large proportion of breast cancer cases are thought related to environmental factors. Identification of specific geographical areas with high risk (clusters) may give clues to potential environmental risk fa...

    Authors: Rikke Baastrup Nordsborg, Jaymie R Meliker, Annette Kjær Ersbøll, Geoffrey M Jacquez, Aslak Harbo Poulsen and Ole Raaschou-Nielsen
    Citation: BMC Cancer 2014 14:255
  7. Although oral cavity, pharyngeal, oesophageal and gastric cancers share some risk factors, no comparative analysis of mortality rate trends in these illnesses has been undertaken in Spain. This study aimed to ...

    Authors: Daniel Seoane-Mato, Nuria Aragonés, Eva Ferreras, Javier García-Pérez, Marta Cervantes-Amat, Pablo Fernández-Navarro, Roberto Pastor-Barriuso and Gonzalo López-Abente
    Citation: BMC Cancer 2014 14:254
  8. Breast cancer is the most common malignancy in women world-wide. Triple negative breast cancer (TNBC) is a highly aggressive subtype that lacks expression of hormone receptors for estrogen, progesterone and hu...

    Authors: Kelly A Avery-Kiejda, Stephen G Braye, John F Forbes and Rodney J Scott
    Citation: BMC Cancer 2014 14:253
  9. The presence of hypoxia in head and neck squamous cell carcinoma (HNSCC) is associated with therapeutic resistance and increased risk of metastasis formation. αB-crystallin (HspB5) is a small heat shock protei...

    Authors: Chantal van de Schootbrugge, Elisabeth MJ Schults, Johan Bussink, Paul N Span, Reidar Grénman, Ger JM Pruijn, Johannes HAM Kaanders and Wilbert C Boelens
    Citation: BMC Cancer 2014 14:252
  10. Renal cell carcinoma (RCC) is a malignant disease that demonstrates resistance to standard chemotherapeutic agents. Yet Active immunization using genetically modified dendritic cells holds promise for the adju...

    Authors: Danhong Wang, Bin Zhang, Haiyan Gao, Guoliang Ding, Qiong Wu, Jinchao Zhang, Li Liao and Hu Chen
    Citation: BMC Cancer 2014 14:251
  11. Notch, IL-1 and leptin are known pro-angiogenic factors linked to breast cancer development, tumor aggressiveness and poor prognosis. A complex crosstalk between these molecules (NILCO) has been reported in br...

    Authors: Laronna S Colbert, Kaamilah Wilson, Sungjin Kim, Yuan Liu, Gabriela Oprea-Ilies, Corey Gillespie, Toi Dickson, Gale Newman and Ruben Rene Gonzalez-Perez
    Citation: BMC Cancer 2014 14:249
  12. Hepatocellular carcinoma (HCC) has been associated with diabetes and obesity, but a possible connection with the metabolic syndrome (MetS) and its potential interaction with hepatitis and cirrhosis are open to...

    Authors: De-cai Yu, Jia Liu, Jun Chen, Jiao-jiao Shao, Xiao Shen, Hong-guang Xia, Chao-jun Li, Bin Xue and Yi-tao Ding
    Citation: BMC Cancer 2014 14:248
  13. The antitumor drug nilotinib has a large inter- and intra individual variability in pharmacokinetics. Adherence to treatment may substantially influence plasma levels and has been recognized as the most import...

    Authors: Christel CLM Boons, Eleonora L Swart, Lonneke Timmers, Peter M van de Ven, Jeroen JWM Janssen and Jacqueline G Hugtenburg
    Citation: BMC Cancer 2014 14:247
  14. Advanced squamous cervical cancer, one of the most commonly diagnosed cancers in women, still remains a major problem in oncology due to treatment failure and distant metastasis. Antitumor therapy failure is d...

    Authors: Ovidiu Balacescu, Loredana Balacescu, Oana Tudoran, Nicolae Todor, Meda Rus, Rares Buiga, Sergiu Susman, Bogdan Fetica, Laura Pop, Laura Maja, Simona Visan, Claudia Ordeanu, Ioana Berindan-Neagoe and Viorica Nagy
    Citation: BMC Cancer 2014 14:246
  15. Hypermethylation of DNA is an epigenetic alteration commonly found in colorectal cancer (CRC) and can also be detected in blood samples of cancer patients. Methylation of the genes helicase-like transcription ...

    Authors: Alexander B Philipp, Dorothea Nagel, Petra Stieber, Rolf Lamerz, Isabel Thalhammer, Andreas Herbst and Frank T Kolligs
    Citation: BMC Cancer 2014 14:245
  16. Prognostic multibiomarker signatures in prostate cancer (PCa) may improve patient management and provide a bridge for developing novel therapeutics and imaging methods. Our objective was to evaluate the associ...

    Authors: Anthony E Rizzardi, Nikolaus K Rosener, Joseph S Koopmeiners, Rachel Isaksson Vogel, Gregory J Metzger, Colleen L Forster, Lauren O Marston, Jessica R Tiffany, James B McCarthy, Eva A Turley, Christopher A Warlick, Jonathan C Henriksen and Stephen C Schmechel
    Citation: BMC Cancer 2014 14:244
  17. Nasopharyngeal carcinoma (NPC) is a highly invasive and metastatic cancer. N,N’-dinitrosopiperazine (DNP), a carcinogen with specificity for nasopharyngeal epithelium, facilitates NPC metastasis. However, the und...

    Authors: Damao Huang, Yuejin Li, Na Liu, Zhenlin Zhang, Zhengke Peng, Chaojun Duan, Xiaowei Tang, Gongjun Tan, Guangrong Yan and Faqing Tang
    Citation: BMC Cancer 2014 14:243
  18. Although breast cancer frequently metastasizes to the bones and brain, rarely breast cancer patients may develop isolated liver metastasis. There is increasing data that anti-HER2 targeted therapy in conjuncti...

    Authors: Hans F Schoellhammer, Felicia Hsu, Courtney Vito, Peiguo Chu, Jinha Park, James Waisman and Joseph Kim
    Citation: BMC Cancer 2014 14:242
  19. Pre-operative chemoradiotherapy (CRT) is the standard treatment in clinical stage T3/4 or node positive rectal cancer. However, there are no established biomarkers that can predict the pathological response an...

    Authors: Sung Hoon Sim, Mi-Hyun Kang, Yu Jung Kim, Keun-Wook Lee, Duck-Woo Kim, Sung-Bum Kang, Keun-Yong Eom, Jae-Sung Kim, Hye Seung Lee and Jee Hyun Kim
    Citation: BMC Cancer 2014 14:241
  20. Deregulation of receptor tyrosine kinases (RTK) contributes to the initiation and progression of intestinal-derived epithelial cancers, including colorectal cancer (CRC). However, the roles of the proximal sig...

    Authors: Véronique Pomerleau, Mélissa Landry, Jimmy Bernier, Pierre H Vachon and Caroline Saucier
    Citation: BMC Cancer 2014 14:240
  21. Physical therapy treatment of patients with lymphedema includes treatment based on the principles of ‘Complete Decongestive Therapy’ (CDT). CDT consists of the following components; skin care, manual lymphatic...

    Authors: Mette Tambour, Berit Tange, Robin Christensen and Bibi Gram
    Citation: BMC Cancer 2014 14:239
  22. Metabolic syndrome (MetS) is increasingly present in breast cancer survivors, possibly worsened by cancer-related treatments, such as chemotherapy. MetS greatly increases risk of cardiovascular disease and dia...

    Authors: Christina M Dieli-Conwright, Joanne E Mortimer, E Todd Schroeder, Kerry Courneya, Wendy Demark-Wahnefried, Thomas A Buchanan, Debu Tripathy and Leslie Bernstein
    Citation: BMC Cancer 2014 14:238
  23. Breast cancer is a heterogeneous disease that can be classified into one of 4 main molecular sub-types: luminal A, luminal B, Her2 over-expressing and basal-like (BL). These tumour sub-types require different ...

    Authors: Annika N Alexopoulou, Colan M Ho-Yen, Vassilis Papalazarou, George Elia, J Louise Jones and Kairbaan Hodivala-Dilke
    Citation: BMC Cancer 2014 14:237
  24. Identification of factors associated with work disability in cancer survivors on long term sick leave may support these survivors in choosing effective measures to facilitate vocational rehabilitation and retu...

    Authors: Peter van Muijen, Saskia FA Duijts, Karin Bonefaas-Groenewoud, Allard J van der Beek and Johannes R Anema
    Citation: BMC Cancer 2014 14:236
  25. MUC16 (CA125) is a large transmembrane mucin protein (> 200 kDa) aberrantly expressed in approximately 80% of human epithelial ovarian cancers (EOC). MUC16 expression in EOC cells is associated with increased ...

    Authors: Isabelle Matte, Denis Lane, Marianne Boivin, Claudine Rancourt and Alain Piché
    Citation: BMC Cancer 2014 14:234
  26. Physician recommendations for cancer screening and prevention are associated with patient compliance. However, time constraints may limit physicians’ ability to provide all recommended preventive services, esp...

    Authors: Deanna Kepka, Alexandria Smith, Christopher Zeruto and K Robin Yabroff
    Citation: BMC Cancer 2014 14:233
  27. Colorectal cancer is an important public health problem in Spain. Over the last decade, several regions have carried out screening programmes, but population participation rates remain below recommended Europe...

    Authors: Carolina Guiriguet-Capdevila, Laura Muñoz-Ortiz, Irene Rivero-Franco, Carme Vela-Vallespín, Mercedes Vilarrubí-Estrella, Miquel Torres-Salinas, Jaume Grau-Cano, Andrea Burón-Pust, Cristina Hernández-Rodríguez, Antonio Fuentes-Peláez, Dolores Reina-Rodríguez, Rosa De León-Gallo, Leonardo Mendez-Boo and Pere Torán-Monserrat
    Citation: BMC Cancer 2014 14:232
  28. Concomitant platinum-based chemotherapy and radiotherapy (CT-RT) is the recommended treatment for unresectable locally advanced stage III non-small cell lung cancer (NSCLC). We conducted a phase II study to ev...

    Authors: Delphine Lerouge, Alain Rivière, Eric Dansin, Christos Chouaid, Cécile Dujon, Roland Schott, Armelle Lavole, Vincent Le Pennec, Elizabeth Fabre, Jacky Crequit, Francis Martin, Stéphanie Dehette, Pierre Fournel, Bénédicte Precheur-Agulhon, Eric Lartigau and Gérard Zalcman
    Citation: BMC Cancer 2014 14:231
  29. Approximately 30% of breast tumors do not express the estrogen receptor (ER) α, which is necessary for endocrine therapy approaches. Studies are ongoing in order to restore ERα expression in ERα-negative breas...

    Authors: Nancy Santos-Martínez, Lorenza Díaz, David Ordaz-Rosado, Janice García-Quiroz, David Barrera, Euclides Avila, Ali Halhali, Heriberto Medina-Franco, María J Ibarra-Sánchez, José Esparza-López, Javier Camacho, Fernando Larrea and Rocío García-Becerra
    Citation: BMC Cancer 2014 14:230
  30. The aim of this study was to examine breast density in relation to breast cancer specific survival and to assess if this potential association was modified by mode of detection. An additional aim was to study ...

    Authors: Ã…sa Olsson, Hanna Sartor, Signe Borgquist, Sophia Zackrisson and Jonas Manjer
    Citation: BMC Cancer 2014 14:229
  31. Less than 1% of all breast cancer cases are found in men, who reportedly have inferior outcomes compared with matched women patients. Ethnic differences may also affect their prognosis. Here, we investigated o...

    Authors: Amr A Soliman, Adel T Denewer, Wael El-Sadda, Ali H Abdel-Aty and Basel Refky
    Citation: BMC Cancer 2014 14:227
  32. AZD3514 inhibits and down regulates the androgen receptor (AR) and has undergone clinical trials in prostate cancer. To provide proof-of-mechanism (POM) in patients, an immunohistochemistry (IHC) method for de...

    Authors: Jeffrey Cummings, Robert Sloane, Karen Morris, Cong Zhou, Matt Lancashire, David Moore, Tony Elliot, Noel Clarke and Caroline Dive
    Citation: BMC Cancer 2014 14:226
  33. IL-17A is a pro-inflammatory cytokine that is normally associated with autoimmune arthritis and other pro-inflammatory conditions. Recently, IL-17A has emerged as a critical factor in enhancing breast cancer (...

    Authors: Lopamudra Das Roy, Mahnaz Sahraei, Jorge L Schettini, Helen E Gruber, Dahlia M Besmer and Pinku Mukherjee
    Citation: BMC Cancer 2014 14:225
  34. Cancer cells may undergo metabolic adaptations that support their growth as well as drug resistance properties. The purpose of this study is to test if oral cancer cells can overcome the metabolic defects intr...

    Authors: Min Zhang, Yang D Chai, Jeffrey Brumbaugh, Xiaojun Liu, Ramin Rabii, Sizhe Feng, Kaori Misuno, Diana Messadi and Shen Hu
    Citation: BMC Cancer 2014 14:223
  35. Primary small cell carcinoma of the esophagus (SCCE) is a highly aggressive disease characterized by early dissemination and poor prognosis. Because of the rarity of this disease, few previous studies have inv...

    Authors: Wei-Wei Chen, Feng Wang, Dong-Sheng Zhang, Hui-Yan Luo, Zhi-Qiang Wang, Feng-Hua Wang, Miao-Zhen Qiu, Chao Ren, Xiao-Li Wei, Wen-Jing Wu, Yu-Hong Li and Rui-Hua Xu
    Citation: BMC Cancer 2014 14:222
  36. We previously reported that women from high-risk families who tested negative for a BRCA1 or BRCA2 (BRCA1/2) mutation were four times more likely to develop breast cancer compared to women in the general populati...

    Authors: Joanne Kotsopoulos, Kelly Metcalfe, Jill Alston, Dina Nikitina, Ophira Ginsburg, Andrea Eisen, Rochelle Demsky, Mohammad Akbari, Kevin Zbuk and Steven A Narod
    Citation: BMC Cancer 2014 14:221
  37. Impairment of cognitive functioning has been reported in several studies in patients treated with chemotherapy. So far, no studies have been published on the effects of the vascular endothelial growth factor r...

    Authors: Sasja F Mulder, Dirk Bertens, Ingrid ME Desar, Kris CP Vissers, Peter FA Mulders, Cornelis JA Punt, Dick-Johan van Spronsen, Johan F Langenhuijsen, Roy PC Kessels and Carla ML van Herpen
    Citation: BMC Cancer 2014 14:219
  38. Recent studies have shown that miR-199a-5p plays opposite roles in cancer initiation and progression of different cancer types, acting as oncogene for some cancer types but as tumor suppressor gene for others....

    Authors: Xu-Jun He, Ying-Yu Ma, Sheng Yu, Xiao-Ting Jiang, Yi-Ding Lu, Liang Tao, Hua-Ping Wang, Zhi-Ming Hu and Hou-Quan Tao
    Citation: BMC Cancer 2014 14:218
  39. Gallbladder cancer is the most frequent malignancy of the bile duct with high aggressive and extremely poor prognosis. The main objective of the paper was to investigate the inhibitory effects of oridonin, a d...

    Authors: Runfa Bao, Yijun Shu, Xiangsong Wu, Hao Weng, Qian Ding, Yang Cao, Maolan Li, Jiasheng Mu, Wenguang Wu, Qichen Ding, Zhujun Tan, Tianyu Liu, Lin Jiang, Yunping Hu, Jianfeng Gu and Yingbin Liu
    Citation: BMC Cancer 2014 14:217
  40. Recently, the cancer stem cell hypothesis has become widely accepted. Cancer stem cells are thought to possess the ability to undergo self-renewal and differentiation, similar to normal stem cells. Nucleostemi...

    Authors: Takayuki Kobayashi, Kenkichi Masutomi, Kenji Tamura, Tomoyuki Moriya, Tamio Yamasaki, Yasuhiro Fujiwara, Shunji Takahashi, Junji Yamamoto and Hitoshi Tsuda
    Citation: BMC Cancer 2014 14:215
  41. Seventy percent of all bladder tumours tend to recur and need intensive surveillance, and a subset of tumours progress to muscle-invasive and metastatic disease. However, it is still difficult to find the adeq...

    Authors: Anja Rogler, Sabine Hoja, Johannes Giedl, Arif B Ekici, Sven Wach, Helge Taubert, Peter J Goebell, Bernd Wullich, Michael Stöckle, Jan Lehmann, Sabrina Petsch, Arndt Hartmann and Robert Stoehr
    Citation: BMC Cancer 2014 14:214
  42. Cancer is the leading cause of deaths in the world. A widening disparity in cancer burden has emerged between high income and low-middle income countries. Closing this cancer divide is an ethical imperative bu...

    Authors: Gerard CC Lim, Emran N Aina, Soon K Cheah, Fuad Ismail, Gwo F Ho, Lye M Tho, Cheng H Yip, Nur A Taib, Kwang J Chong, Jayendran Dharmaratnam, Matin M Abdullah, Ahmad K Mohamed, Kean F Ho, Kananathan Ratnavelu, Chiao M Lim, Kin W Leong…
    Citation: BMC Cancer 2014 14:212

Featured videos

View featured videos from across the BMC-series journals